Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms

Summary

The purpose of this study is to determine if a single dose of pregabalin 300mg in patients receiving medications for sedative-hypnotic withdrawal symptoms will produce meaningful differences in measures of "drug liking" and "drug high" as compared to placebo.

Timeline

Start

2015-04

Primary completion

2016-03

Completion

2016-03

Drugs

Indications